Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UNIPROT:P02794 (ferritin)
 17,525 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

A STEM VG HB 501 equipped with a Gatan spectrometer has been interfaced to a PDP 11-34 computer. Digital energy filtered images have been recorded with several energy windows on both sides of a characteristic level, so that the exact background can be stripped under the core loss signal for each pixel. Results concern the distribution of nitrogen (K-edge at 402 eV), oxygen (K-edge at 532 eV) and iron (L23 edge at 705 eV) in embedded sections of bone marrow. The present performances of the system allow the detection of composition variations of 1 to 2% for these elements, with a lateral accuracy of the order of 5 nm in a section of 50 nm thickness. Individual ferritin molecules distributed within the section are clearly imaged and analyzed with the characteristic iron edge.
 ...
PMID:Electron energy loss chemical mapping of low Z elements in biological sections. 663 71

Hair loss in otherwise healthy women presents several challenges for the clinician. The first is to identify the cause, which may be complicated by two or more secondary factors; the second is to find effective treatments; and the third is to establish requirements for long-term management. An optimal hair growth potential is considered to exist when specific parameters for biochemical variables are operating. These include red blood cell and serum folate concentrations within the normal range, serum vitamin B12 levels between 300 and 1000 ng/L, hemoglobin levels greater than 13.0 g/dL, and serum ferritin concentrations of 70 ng/mL or greater. The two predominant disturbances, diffuse androgen-dependent alopecia and chronic telogen effluvium, both require months of treatment before the benefits can be seen. During this time several follow-up investigations and reassuring consultations must occur. Current systemic antiandrogen regimens are highly effective, but the prospect of long-term therapy, possibly for life, is daunting. For some patients there is no systemic choice and topical treatment is the only option. Minoxidil is the only topical preparation currently licensed, but with no quantitative long-term data available, assessing its value in the long-term treatment of androgen-dependent alopecia is difficult.
 ...
PMID:Management of hair loss in women. 843 17